Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Kardiologia polska

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.5603/KP.2017.0237PMID 29251761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the lercanidipine–enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database

  2016cited by this paper
• Cluster Randomized Controlled Trial

  2015cited by this paper
• Zasady postępowania w nadciśnieniu tętniczym — 2015 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Próba komentarza na temat zmian i ich zasadności

  2015cited by this paper
• Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension

  2015cited by this paper
• Zasady postępowania w nadciśnieniu tętniczym — 2015 rok

  2015influential reference
• Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.

  2015cited by this paper
• Factors associated with resistant hypertension in a large cohort of hypertensive patients: the Pol-Fokus study.

  2015cited by this paper
• Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.

  2015cited by this paper
• A promising choice in hypertension treatment: Fixed-dose combinations

  2014cited by this paper
• Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study

  2014cited by this paper
• Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)

  2014cited by this paper
• [Effect of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus. A meta-analysis].

  2014cited by this paper
• A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.

  2013cited by this paper
• Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients

  2012cited by this paper
• Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.

  2012cited by this paper
• Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice

  2011cited by this paper
• Zasady postępowania w nadciśnieniu tętniczym — 2011 rok

  2011influential reference
• Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis

  2010cited by this paper
• Effect of valsartan on the incidence of diabetes and cardiovascular events.

  2010cited by this paper
• Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

  2010cited by this paper
• Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.

  2009cited by this paper
• Miejsce gotowych połączeń lekowych w terapii nadciśnienia tętniczego - stanowisko ekspertów

  2009cited by this paper
• : a cluster randomized controlled trial

  2009cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX‐FAST) Study

  2008cited by this paper
• An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.

  2008cited by this paper
• 2007 Guidelines for the management of arterial hypertension

  2007cited by this paper
• 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2007cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Guidelines for management of arterial hypertension

  2007cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  2004cited by this paper
• Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

  2004cited by this paper
• Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach

  2004cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack.

  2003cited by this paper
• Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol☆

  2002cited by this paper
• The Conduit Artery Functional Endpoint (CAFE) study in ASCOT

  2001cited by this paper
• Compliance with antihypertensive therapy.

  1999cited by this paper

• Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development

  2022influential citation
• TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

  2022cites this paper
• Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure?

  2021cites this paper
• „Polypill“ u seniorov: možná frekvencia používania fixných kombinácií liečiv podľa údajov zo štúdie SAFIS / Polypill in seniors: possible frequency of fixed drug combination according to the SAFIS study

  2020cites this paper
• Education, cardiovascular risk factors and blood pressure control in hypertensive outpatients.

  2018cites this paper
• Random blood glucose and blood pressure tests with Korotkoff sounds as the identification of risk factors for cardiovascular disorders

  2018cites this paper